← Back to Search

Obervational group for None

N/A
Recruiting
Led By Lindsay Darthard, LNFA
Research Sponsored by Turtle Shell Technologies Pvt. Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

Enhancing patient monitoring in SNFs and ALFs is crucial due to challenges in recognizing deteriorating health. Gaps in vital sign checks lead to missed indicators and adverse outcomes. Turtle Shell Technologies' Dozee Pro NX offers continuous non-invasive monitoring, alerting healthcare providers of vital sign changes. This clinical study aims to evaluate Dozee Pro Nx's impact on patient outcomes, practitioner efficiency, and healthcare costs in SNFs and ALFs, addressing gaps in care delivery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Care Escalation and/or Transfers (Subgroup- ER visits, Surgical Interventions & Hospitalizations, ICU Admissions)
Secondary outcome measures
Care pathway mapping
HCP experience response data

Trial Design

2Treatment groups
Experimental Treatment
Group I: Obervational groupExperimental Treatment1 Intervention
Patients admitted in the SNF facility during the study period
Group II: Control groupExperimental Treatment0 Interventions
Historical control with patients admitted in the SNF before the study period

Find a Location

Who is running the clinical trial?

Turtle Shell Technologies Pvt. Ltd.Lead Sponsor
2 Previous Clinical Trials
61 Total Patients Enrolled
Lindsay Darthard, LNFAPrincipal InvestigatorOak Village Healthcare

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

I do studies as a way to help people.
PatientReceived 2+ prior treatments
~100 spots leftby Apr 2025